Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Middle Region) Peptide
Aperçu rapide pour Teratocarcinoma-Derived Growth Factor 1 (TDGF1) (Middle Region) Peptide (ABIN984931)
Antigène
Origine
Source
Application
-
-
Protein Region
- Middle Region
-
Séquence
- LRCFPQAFLP GCDGLVMDEH LVASRTPELP PSARTTTFML VGICLSIQSY
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-TDGF1 Antibody(ARP45440_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
-
Sujet
-
This gene encodes an epidermal growth factor-related protein that contains a cripto, FRL-1, and cryptic domain. The encoded protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants.
Alias Symbols: CR, CRGF, CRIPTO, Cripto-1
Protein Interaction Partner: ACVR1B,ACVR1C,ANG,BAT3,C1orf103,COPS6,GDF9,ACVR1B,ANG,BAT3,C1orf103,COPS6,GDF9
Protein Size: 188 -
Poids moléculaire
- 21 kDa
-
ID gène
- 6997
-
NCBI Accession
- NM_003212, NP_003203
-
UniProt
- P13385
Antigène
-